Do Young Kim

Professor

Yonsei University College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Medical Imaging Medical Imaging professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Do Young Kim is a Professor at Yonsei University College of Medicine in South Korea. His research focuses on hepatocellular carcinoma (HCC), including the use of systemic therapies, biomarker identification, and novel imaging techniques for surveillance and management. Recent publications highlight his contributions to understanding the relationship between aspirin use and liver cancer risk, as well as the clinical implications of immunotherapy in early-stage HCC patients.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (21)

Jun Yong Park

SOUTH KOREA

Do Young Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis

Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria

Roadmap for HCC Surveillance and Management in the Asia Pacific

Identification of new biomarkers of hepatic cancer stem cells through proteomic profiling

Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma

Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”

Non-contrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance: A randomized, single-center trial

Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere

Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center

Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents

Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide

Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study

T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”

Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis

MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study

Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea

A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study

Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology

Fatty Liver Index as a Simple and Useful Predictor for 10-year Cardiovascular Disease Risks Determined by Framingham Risk Score in the General Korean Population

Collaborators (21)

Jun Yong Park

Sunyoung Lee

Ji-Hye Kim

Beom Kyung Kim

Jong Yun Won

Mi Na Kim

Yong-ho Lee

Yoon Jun Kim

Si Hyun Bae

Kwanjoo Lee

Minjong Lee

Dong-Sook Kim

Eun Seok Kang

Hye Won Lee

Heechul Nam

Seung Up Kim

JUNG IL LEE

Eugene Han

Jeong Won Jang

Byung-Wan Lee

Chansik An

Make your next move.